|
Volumn 40, Issue 1, 2001, Pages 11-18
|
Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain
|
Author keywords
C fos; Dopamine; Methamphetamine; Neurodevelopment; Phencyclidine
|
Indexed keywords
DOPAMINE;
METHAMPHETAMINE;
N METHYL DEXTRO ASPARTIC ACID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
PHENCYCLIDINE;
ANIMAL BEHAVIOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DOPAMINERGIC ACTIVITY;
DOPAMINERGIC SYSTEM;
FEMALE;
IN SITU HYBRIDIZATION;
LIMBIC CORTEX;
NERVE CELL DIFFERENTIATION;
NEWBORN;
NONHUMAN;
NUCLEUS ACCUMBENS;
ONCOGENE C FOS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
RECEPTOR BLOCKING;
SCHIZOPHRENIA;
STATISTICAL ANALYSIS;
STEREOTYPY;
ANIMALS;
ANIMALS, NEWBORN;
DOPAMINE;
METHAMPHETAMINE;
NEURAL PATHWAYS;
NEURONS;
NUCLEUS ACCUMBENS;
PHENCYCLIDINE;
PROTO-ONCOGENE PROTEINS C-FOS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, N-METHYL-D-ASPARTATE;
RNA, MESSENGER;
SCHIZOPHRENIA;
STEREOTYPED BEHAVIOR;
VENTRAL TEGMENTAL AREA;
|
EID: 0035115368
PISSN: 08874476
EISSN: None
Source Type: Journal
DOI: 10.1002/1098-2396(200104)40:1<11::AID-SYN1021>3.0.CO;2-I Document Type: Article |
Times cited : (11)
|
References (53)
|